SamiNMalekMD

Oncology • Ann Arbor, MI

Hematologic Oncology

Physician

Join to view full profile

Dr. Malek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Malek's full profile

Already have an account?

Office
1500 E Medical Center Dr
Ann Arbor, MI 48109
Phone+1 734-936-4000

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2001 - 2004
Baylor College of MedicineResidency, Internal Medicine, 1997 - 2001
University Hamburg, Krankenhaus Eppendorf, Fak MedClass of 1993

Certifications & Licensure

MI State Medical License 2004 - 2026
MD State Medical License 2001 - 2005
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013

Clinical Trials

A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL Start of enrollment: 2012 Nov 01
Active, not recruiting
Phase 2

Publications & Presentations

PubMed

STAT6 mutations compensate for CREBBP mutations and hyperactivate IL4/STAT6/RRAGD/mTOR signaling in follicular lymphoma.
Qiangqiang Shao, Karan Bedi, Isabella A Malek, Kerby Shedden, Sami N Malek
Leukemia. 2025-02-05
Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.
Qiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, Karan Bedi, Mohamed Rizk
Leukemia. 2025-01-01
Correction: Aberrant BCAT1 expression augments MTOR activity and accelerates disease progression in chronic lymphocytic leukemia.
Qiangqiang Shao, Jedrzej Wykretowicz, Nan Hu, Karan Bedi, Mohamed Rizk
Leukemia. 2025-01-01

Abstracts/Posters

Paired Analyses of AML at Diagnosis and Relapse By Single-Cell RNA Sequencing Identifies Two Distinct Relapse Patterns
Sami Malek, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

Impact of Disease Burden in Acute Myeloid Leukemia
2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018

Grant Support

Genomic Complexity And Clinical Outcome In Chronic Lymphocytic LeukemiaNational Cancer Institute2009–2012
Genomic Profiling And Clinical Outcome In Chronic Lymphocytic LeukemiaNational Cancer Institute2007–2008